A major international study has assessed key bacterial targets that could form the basis of a new maternal vaccine to protect ...

A comprehensive international study has identified bacterial targets for a maternal vaccine to protect newborns from deadly ...

Sepsis leads to life-threatening organ failure due to dysregulated host responses to infection and presents uniquely across age groups. Neonatal sepsis, affecting infants in their first 28 days, ...

A genetic signature in newborns can predict neonatal sepsis before symptoms even start to show, according to a new study. The study, led by University of British Columbia and Simon Fraser University ...

Among the 981,869 children, 0.8% were diagnosed with sepsis and less than 0.1% diagnosed with meningitis; overall, 1.2% of children developed epilepsy during the study period. Children with clinically ...

Researchers are calling for an urgent overhaul of diagnostic and treatment guidelines for infections in newborn babies, after a University of Sydney-led study revealed frontline treatments for sepsis ...

A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient ...

A new study into sepsis in neonatal babies has uncovered the secrets of the bacteria’s success in causing this life-threatening condition. Using genomic sequencing, they have found how certain strains ...

University of Maryland School of Medicine (UMSOM) researchers at the Center for Vaccine Development and Global Health (CVD) have been awarded $3.96 million to develop a maternal vaccine that prevents ...